Allurion Technologies Inc. (ALUR )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol ALUR
- Company Allurion Technologies Inc.
- Price $1.27
- Changes Percentage -27.71
- Change -0.49
- Day Low $1.03
- Day High $1.35
- Year High $4.18
- Year Low $0.95
- Market Cap $9,825,366
- Price Avg 50 EMA (D) $1.43
- Price Avg 200 EMA (D) $2.07
- Exchange NYSE
- Volume 11,235,776
- Average Volume 98,318
- Open $1.29
- Previous Close $1.75
- EPS -16.2
- PE -0.08
- Earnings Announcement 2026-03-25 13:30:00
- Shares Outstanding $7,767,088
Company brief: ALLURION TECHNOLOGIES INC. (ALUR )
- Healthcare
- Medical - Devices
- Dr. Shantanu K. Gaur M.D.
- https://www.allurion.com
- US
- N/A
- 03-29-2021
- US02008G1022
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.
ALUR Corporation News
Allurion Announces Exercise of Warrants for $3.0 Million in Gross Proceeds
businesswire.com -- NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (NYSE: ALUR) (the “Company” or “Allurion”), a pioneer in metabolically healthy weight loss, today announced the entry into a definit...
Allurion Receives U.S. FDA Approval
businesswire.com -- NATICK, Mass.--(BUSINESS WIRE)---- $ALUR--Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced that the U.S. Food and Drug Administration (FDA) has...